Company

T7 Therapeutics, Inc.

T7 Therapeutics develops monoclonal antibodies for autoimmune diseases.

About

T7 Therapeutics researches and develops biotechnology drugs for immune system illnesses. Its work includes monoclonal antibodies for autoimmune diseases. Founded in 2021, the company is based in Delaware, US. It raised venture funding from TVM Capital Life Science in November 2021.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in